1Department of Preclinical Biostatistics, R.W. Johnson Pharmaceutical Research Institute, Raritan, New Jersey 08869-0602, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
A new method, SD2B, consistently outperforms the SD2L procedure for determining the minimum effective dose in dose-response studies. Replacing linear contrast tests with Bartholomew's test significantly improves efficiency, especially in complex scenarios.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: